Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 8, no: 2 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 11 |
GO:0016020 | membrane | 2 | 11 |
GO:0031090 | organelle membrane | 3 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: E9ACT6
Term | Name | Level | Count |
---|---|---|---|
GO:0006766 | vitamin metabolic process | 3 | 11 |
GO:0006775 | fat-soluble vitamin metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018200 | peptidyl-glutamic acid modification | 6 | 2 |
GO:0018214 | protein carboxylation | 5 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0042180 | cellular ketone metabolic process | 3 | 11 |
GO:0042373 | vitamin K metabolic process | 5 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901661 | quinone metabolic process | 4 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 11 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 3 | 11 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 4 | 11 |
GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor | 4 | 11 |
GO:0047057 | vitamin-K-epoxide reductase (warfarin-sensitive) activity | 5 | 11 |
GO:0048038 | quinone binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.611 |
CLV_PCSK_PC1ET2_1 | 141 | 143 | PF00082 | 0.537 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.506 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.535 |
DEG_SPOP_SBC_1 | 150 | 154 | PF00917 | 0.399 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.242 |
DOC_USP7_MATH_1 | 149 | 153 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.199 |
DOC_USP7_UBL2_3 | 156 | 160 | PF12436 | 0.380 |
DOC_USP7_UBL2_3 | 3 | 7 | PF12436 | 0.354 |
LIG_APCC_ABBA_1 | 25 | 30 | PF00400 | 0.305 |
LIG_BRCT_BRCA1_1 | 54 | 58 | PF00533 | 0.273 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.372 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.305 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.393 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.241 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.306 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.413 |
LIG_GBD_Chelix_1 | 107 | 115 | PF00786 | 0.360 |
LIG_IRF3_LxIS_1 | 90 | 97 | PF10401 | 0.227 |
LIG_LIR_Apic_2 | 62 | 68 | PF02991 | 0.242 |
LIG_LIR_Gen_1 | 117 | 126 | PF02991 | 0.363 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 117 | 121 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 38 | 42 | PF02991 | 0.242 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.142 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.241 |
LIG_Pex14_2 | 54 | 58 | PF04695 | 0.259 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.323 |
LIG_SH2_STAP1 | 21 | 25 | PF00017 | 0.247 |
LIG_SH2_STAP1 | 80 | 84 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.226 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.241 |
LIG_SUMO_SIM_anti_2 | 91 | 97 | PF11976 | 0.294 |
LIG_SUMO_SIM_par_1 | 109 | 114 | PF11976 | 0.297 |
LIG_SUMO_SIM_par_1 | 91 | 97 | PF11976 | 0.310 |
LIG_Vh1_VBS_1 | 67 | 85 | PF01044 | 0.213 |
MOD_CK1_1 | 143 | 149 | PF00069 | 0.352 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.389 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.342 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.226 |
MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.580 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.247 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.407 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.420 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.250 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.243 |
MOD_N-GLC_1 | 128 | 133 | PF02516 | 0.379 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.326 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.267 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.260 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.183 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.290 |
MOD_OFUCOSY | 43 | 50 | PF10250 | 0.411 |
MOD_Plk_1 | 128 | 134 | PF00069 | 0.379 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.341 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.312 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.251 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.251 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.314 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.212 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.332 |
TRG_ER_diLys_1 | 157 | 162 | PF00400 | 0.499 |
TRG_NLS_Bipartite_1 | 141 | 160 | PF00514 | 0.324 |
TRG_NLS_MonoExtC_3 | 155 | 160 | PF00514 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IB97 | Leptomonas seymouri | 71% | 100% |
A0A0S4J6N8 | Bodo saltans | 51% | 100% |
A0A1X0NR17 | Trypanosomatidae | 56% | 94% |
A0A3R7K875 | Trypanosoma rangeli | 51% | 100% |
A0A3S7X0Y5 | Leishmania donovani | 98% | 100% |
A4HFZ6 | Leishmania braziliensis | 78% | 100% |
A4I315 | Leishmania infantum | 98% | 100% |
C9ZJI4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9AZC5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q6B4J2 | Bos taurus | 36% | 99% |
Q6TEK3 | Rattus norvegicus | 31% | 92% |
Q6TEK4 | Rattus norvegicus | 33% | 100% |
Q6TEK5 | Mus musculus | 31% | 92% |
Q8N0U8 | Homo sapiens | 32% | 92% |
Q9BQB6 | Homo sapiens | 38% | 99% |
Q9CRC0 | Mus musculus | 36% | 100% |